A mathematical model provides new insights into solid organ transplant-associated acute graft-versus-host disease

2016 ◽  
Vol 30 (9) ◽  
pp. 1173-1177 ◽  
Author(s):  
Armin Rashidi
Transfusion ◽  
2016 ◽  
Vol 56 (4) ◽  
pp. 962-969 ◽  
Author(s):  
Brett L. Houston ◽  
Matthew Yan ◽  
Kathryn Tinckam ◽  
Suzanne Kamel-Reid ◽  
Hong Chang ◽  
...  

1970 ◽  
Vol 11 (2) ◽  
Author(s):  
Janeve Desy MD ◽  
Marc Deschenes MD

Graft Versus Host Disease (GVHD) is a rare complication of liver transplantation with a mortality rate exceeding 65%. A 53-year-old male presented with a diffuse maculopapular rash, diarrhea, lymphopenia, fever, and confusion 14 days after orthotopic liver transplantation for hepatitis B cirrhosis. Skin biopsy and HLA- typing of peripheral blood confirmed a diagnosis of solid organ transplant related GVHD. This report summarizes what is known about this disease and emphasizes the importance of early diagnosis, which is one of the only factors known to improve the mortality of this deadly condition.


2010 ◽  
Vol 134 (8) ◽  
pp. 1220-1224 ◽  
Author(s):  
Yaxia Zhang ◽  
Phillip Ruiz

Abstract Solid organ transplant–associated graft-versus-host disease is an infrequent and potentially lethal complication. The incidence of this complication varies according to the type of organ transplant with higher rates associated with liver and small bowel transplants. The clinical presentation typically includes fever and skin rash, and most cases quickly advance to become a multisystem disease affecting the bone marrow and other nontransplanted solid organs. The diagnosis is based on the clinical symptoms, pathologic changes in biopsied tissues, and systemic lymphoid chimerism. The mortality of this disease can exceed 75% after liver transplant and most patients die from infections or hemorrhage due to bone marrow failure. There is no standard treatment strategy for this complication, and the management mainly consists of both prophylaxis and immediate treatment without delay. This short review summarizes the current pathogenesis, diagnosis, and treatment of this entity.


2021 ◽  
Vol 27 (3) ◽  
pp. S279-S280
Author(s):  
Nino Balanchivadze ◽  
Muhammad Shahid ◽  
Julia Bachler ◽  
George Divine ◽  
Kylie Springer ◽  
...  

2019 ◽  
Vol 20 (2) ◽  
pp. 589-592 ◽  
Author(s):  
Miriam T. Jacobs ◽  
Marissa Olson ◽  
Bruna Pellini Ferreira ◽  
Ramon Jin ◽  
Ramsey Hachem ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-3
Author(s):  
Muneeb Ilyas ◽  
Elika Hoss ◽  
David J. DiCaudo ◽  
Hasan Khamash ◽  
Mark R. Pittelkow ◽  
...  

Introduction. The phenomenon of graft-versus-host disease, a solid organ transplant recipient, is a rare development with a very poor prognosis. Case Presentation. A 40-year-old woman with type 1 diabetes developed cutaneous graft-versus-host disease following second pancreas transplantation. Conclusion. The development of a nonspecific rash in the early posttransplant period following a pancreas transplant warrants suspicion for graft-versus-host disease.


Thorax ◽  
2018 ◽  
Vol 73 (5) ◽  
pp. 489-492 ◽  
Author(s):  
Jonathan R Brestoff ◽  
Alexandre T Vessoni ◽  
Kirsten A Brenner ◽  
Geoffrey L Uy ◽  
John F DiPersio ◽  
...  

Familial pulmonary fibrosis is associated with loss-of-function mutations in telomerase reverse transcriptase (TERT) and short telomeres. Interstitial lung diseases have become the leading indication for lung transplantation in the USA, and recent data indicate that pathogenic mutations in telomerase may cause unfavourable outcomes following lung transplantation. Although a rare occurrence, solid organ transplant recipients who develop acute graft-versus-host disease (GVHD) have very poor survival. This case report describes the detection of a novel mutation in TERT in a patient who had lung transplantation for familial pulmonary fibrosis and died from complications of acute GVHD.


Sign in / Sign up

Export Citation Format

Share Document